Clinical trial
Fractional Ablative CO2 Laser in the Treatment of the Genitourinary Syndrome of Menopause
NCT03939078 is registered in ClinicalTrials.gov with Universidade Federal Fluminense as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fractional Ablative CO2 Laser in the Treatment of the Genitourinary Syndrome of Menopause
- Lead sponsor
- Universidade Federal Fluminense
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 5, 2018
- Completion date
- March 5, 2020
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
menopause, urinary incontinence, vaginal atrophy